SS Innovations Boosts Access to Robotic Surgery
SS Innovations International, Inc. (OTC: SSII), a pioneering developer of surgical robotic technologies, is making significant strides in its global mission to provide advanced medical solutions. With new regulatory approvals for its SSi Mantra 3 Surgical Robotic System in both the Philippines and Ukraine, the company is positioned to transform surgical care in these regions.
Regulatory Approvals Enhance Global Reach
In partnership with RBGM Medical Express Sales Inc., based in the Philippines, SS Innovations proudly announces the successful registration of the SSi Mantra 3. This milestone enables Filipino hospitals and healthcare professionals to access leading-edge surgical robotics technology, aligning with the country’s expanding healthcare market, which has nearly 4,000 hospitals.
RBGM President Don Gabriel Oligar T. Cariño III emphasized the revolutionary nature of this technology, stating that SS Innovations aims to provide cost-effective, high-quality robotic solutions tailored to local needs. The collaboration is dedicated to improving clinical outcomes and enhancing healthcare services for the Filipino population.
The Impact of Advanced Surgical Robotics
The introduction of the SSi Mantra 3 in the Philippines marks an evolution in surgical practices. Healthcare providers will benefit from enhanced precision and efficiency in operations, catering to a variety of complex procedures. This transition is pivotal for ensuring that patients receive high-quality treatment options with minimal complications.
Opportunities in Ukraine Amid Challenges
Alongside developments in the Philippines, SS Innovations has received a Certificate of Conformity from the Ukrainian Government for the SSi Mantra 3. This certification underscores that the system meets stringent international standards for quality and safety. Given the ongoing efforts to restore Ukraine's healthcare infrastructure, this partnership presents exciting opportunities for enhancing surgical capabilities in the region.
Ms. Roksolana Dmytriv, Head of International Communications and Regulatory Affairs at Loran Group, highlighted the critical importance of reliable medical technologies for surgical institutions. She expressed optimism that the SSi Mantra 3 will empower Ukrainian medical professionals to perform complex surgeries more effectively, ranging from urology to gynecology.
Rebuilding Medical Infrastructure
Despite facing adversities in the healthcare landscape, the approval signifies a renewed commitment to advancing surgical technology in Ukraine. The SSi Mantra 3 aims to elevate healthcare standards, offering precise surgical interventions that enhance patient well-being. This progress is crucial as the nation seeks to recover and upgrade its medical facilities.
SS Innovations’ Vision for Global Healthcare
Dr. Vishwa Srivastava, President and COO of SS Innovations, expressed gratitude for the opportunities to improve healthcare access in underserved populations. The company’s vision is to make state-of-the-art medical technologies available worldwide, especially in regions that might otherwise lack access to such innovations.
The launch of SSi Mantra 3 Surgical Robotic Programs in the Philippines and Ukraine is a step towards realizing this vision. With their expertise, SS Innovations aims to deliver top-tier care and improve patient outcomes significantly.
About SS Innovations
SS Innovations International, Inc. (OTC: SSII) is dedicated to making robotics in surgery more affordable and accessible. Their flagship products, including the SSi Mantra Surgical Robotic System, are designed to support a wide array of surgical procedures. The company continues to expand its influence in the global market for surgical robotics, with plans for further initiatives in the U.S. and European Union.
Frequently Asked Questions
What is the SSi Mantra 3 Surgical Robotic System?
The SSi Mantra 3 is an advanced surgical robotic system designed to facilitate various complex surgical procedures with high precision and safety.
How does SS Innovations plan to enhance healthcare access?
By securing regulatory approvals in new markets, SS Innovations aims to provide healthcare professionals with cutting-edge technology, ultimately improving patient care.
What markets is SS Innovations targeting with their robotic systems?
Currently, SS Innovations is focusing on expanding in the Philippines and Ukraine, with future plans to enter the U.S. and European markets.
What partnerships does SS Innovations have in these regions?
In the Philippines, SS Innovations partners with RBGM Medical Express Sales Inc., while in Ukraine, they collaborate with Loran Group.
What impact will the SSi Mantra 3 have on surgical outcomes?
The system is expected to enhance surgical precision, reduce complications, and enable faster recovery times for patients undergoing complex procedures.
